What medtech’s selective dealmaking signals for 2026
Medtech deal activity has become more selective, with companies focusing investments on higher-growth and higher-margin categories.
Useful signal?
Sign in with GitHub below to react 👍 / 👎, or comment if a category looks wrong — your reactions help curate this feed. How feedback works